ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 255 filers reported holding ICU MED INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,991,333 | -28.9% | 125,967 | +6.5% | 0.04% | -23.1% |
| Q2 2023 | $21,078,452 | +3.1% | 118,292 | -4.5% | 0.05% | +2.0% |
| Q1 2023 | $20,438,708 | +9.2% | 123,901 | +4.2% | 0.05% | -1.9% |
| Q4 2022 | $18,721,066 | +52.3% | 118,879 | +45.6% | 0.05% | +44.4% |
| Q3 2022 | $12,295,000 | -13.9% | 81,644 | -6.0% | 0.04% | -7.7% |
| Q2 2022 | $14,284,000 | -33.3% | 86,890 | -9.6% | 0.04% | -18.8% |
| Q1 2022 | $21,407,000 | -27.6% | 96,154 | -22.8% | 0.05% | -12.7% |
| Q4 2021 | $29,573,000 | +5.3% | 124,601 | +3.5% | 0.06% | +3.8% |
| Q3 2021 | $28,083,000 | +11.0% | 120,331 | -2.1% | 0.05% | +12.8% |
| Q2 2021 | $25,295,000 | +4.2% | 122,910 | +4.0% | 0.05% | 0.0% |
| Q1 2021 | $24,283,000 | +0.0% | 118,203 | +4.4% | 0.05% | -6.0% |
| Q4 2020 | $24,282,000 | +13.2% | 113,203 | -3.6% | 0.05% | 0.0% |
| Q3 2020 | $21,460,000 | -3.5% | 117,411 | -2.7% | 0.05% | -9.1% |
| Q2 2020 | $22,234,000 | -34.9% | 120,626 | -28.7% | 0.06% | -45.0% |
| Q1 2020 | $34,136,000 | +3.0% | 169,179 | -4.5% | 0.10% | +35.1% |
| Q4 2019 | $33,154,000 | +18.0% | 177,184 | +0.6% | 0.07% | +7.2% |
| Q3 2019 | $28,105,000 | +25.3% | 176,095 | +97.8% | 0.07% | +27.8% |
| Q2 2019 | $22,424,000 | +278.3% | 89,016 | +259.4% | 0.05% | +260.0% |
| Q1 2019 | $5,928,000 | +297.3% | 24,765 | +281.2% | 0.02% | +275.0% |
| Q4 2018 | $1,492,000 | -80.9% | 6,496 | -76.5% | 0.00% | -77.8% |
| Q3 2018 | $7,823,000 | -69.1% | 27,666 | -67.9% | 0.02% | -75.7% |
| Q2 2018 | $25,314,000 | +742.1% | 86,204 | +623.9% | 0.07% | +722.2% |
| Q1 2018 | $3,006,000 | +42842.9% | 11,908 | +35984.8% | 0.01% | – |
| Q4 2017 | $7,000 | +16.7% | 33 | -2.9% | 0.00% | – |
| Q3 2017 | $6,000 | 0.0% | 34 | -5.6% | 0.00% | – |
| Q2 2017 | $6,000 | -33.3% | 36 | -41.9% | 0.00% | – |
| Q1 2017 | $9,000 | -99.4% | 62 | -99.4% | 0.00% | -100.0% |
| Q4 2016 | $1,613,000 | +4259.5% | 10,949 | +3662.5% | 0.01% | – |
| Q3 2016 | $37,000 | +32.1% | 291 | +17.8% | 0.00% | – |
| Q2 2016 | $28,000 | -97.0% | 247 | -97.3% | 0.00% | -100.0% |
| Q1 2016 | $947,000 | -4.3% | 9,097 | +3.6% | 0.00% | 0.0% |
| Q4 2015 | $990,000 | +54.0% | 8,780 | +49.5% | 0.00% | +50.0% |
| Q3 2015 | $643,000 | +1848.5% | 5,872 | +1617.0% | 0.00% | – |
| Q2 2015 | $33,000 | -90.0% | 342 | -90.3% | 0.00% | -100.0% |
| Q1 2015 | $330,000 | +6.5% | 3,540 | -6.3% | 0.00% | 0.0% |
| Q4 2014 | $310,000 | – | 3,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |